- Home
- HLLY vs XFOR Comparison
HLLY vs XFOR Comparison
Compare HLLY & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLLY
- XFOR
- Stock Information
- Founded
- HLLY 1903
- XFOR 2014
- Country
- HLLY United States
- XFOR United States
- Employees
- HLLY N/A
- XFOR N/A
- Industry
- HLLY Auto Parts:O.E.M.
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLLY Consumer Discretionary
- XFOR Health Care
- Exchange
- HLLY Nasdaq
- XFOR Nasdaq
- Market Cap
- HLLY 344.6M
- XFOR 320.0M
- IPO Year
- HLLY N/A
- XFOR N/A
- Fundamental
- Price
- HLLY $4.07
- XFOR $3.85
- Analyst Decision
- HLLY Strong Buy
- XFOR Strong Buy
- Analyst Count
- HLLY 7
- XFOR 3
- Target Price
- HLLY $4.43
- XFOR $34.67
- AVG Volume (30 Days)
- HLLY 1.8M
- XFOR 692.1K
- Earning Date
- HLLY 11-07-2025
- XFOR 11-05-2025
- Dividend Yield
- HLLY N/A
- XFOR N/A
- EPS Growth
- HLLY N/A
- XFOR N/A
- EPS
- HLLY N/A
- XFOR N/A
- Revenue
- HLLY $598,132,000.00
- XFOR $33,979,000.00
- Revenue This Year
- HLLY $0.19
- XFOR $1,307.51
- Revenue Next Year
- HLLY $5.09
- XFOR N/A
- P/E Ratio
- HLLY N/A
- XFOR N/A
- Revenue Growth
- HLLY N/A
- XFOR 2925.74
- 52 Week Low
- HLLY $1.60
- XFOR $1.35
- 52 Week High
- HLLY $4.10
- XFOR $26.83
- Technical
- Relative Strength Index (RSI)
- HLLY 70.96
- XFOR 56.88
- Support Level
- HLLY $3.58
- XFOR $3.49
- Resistance Level
- HLLY $3.90
- XFOR $3.85
- Average True Range (ATR)
- HLLY 0.24
- XFOR 0.24
- MACD
- HLLY 0.05
- XFOR -0.00
- Stochastic Oscillator
- HLLY 96.50
- XFOR 89.06
About HLLY Holley Inc.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.